Manas K. Majumdar
Keine laufenden Positionen mehr
Profil
Manas K.
Majumdar worked as a Biology Director at TCG Lifesciences Pvt Ltd.
and as a Principal at Osiris Therapeutics, Inc. He earned a doctorate degree from Indiana State University in 1991.
Ehemalige bekannte Positionen von Manas K. Majumdar
Unternehmen | Position | Ende |
---|---|---|
OSIRIS THERAPEUTICS, INC. | Corporate Officer/Principal | - |
TCG Lifesciences Pvt Ltd.
TCG Lifesciences Pvt Ltd. Miscellaneous Commercial ServicesCommercial Services TCG Lifesciences Pvt Ltd. develops pharmaceutical and biotechnology products. It offers services such as medicinal chemistry synthesis, parallel medicinal, custom synthesis, cGMP kilo scale synthesis, computer aided drug design, medicinal chemistry, molecular pharmacology, and electrophysiology. The company was founded by Purnendu Chatterjee in 1998 and is headquartered in Kolkata, India. | Corporate Officer/Principal | - |
Ausbildung von Manas K. Majumdar
Indiana State University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
TCG Lifesciences Pvt Ltd.
TCG Lifesciences Pvt Ltd. Miscellaneous Commercial ServicesCommercial Services TCG Lifesciences Pvt Ltd. develops pharmaceutical and biotechnology products. It offers services such as medicinal chemistry synthesis, parallel medicinal, custom synthesis, cGMP kilo scale synthesis, computer aided drug design, medicinal chemistry, molecular pharmacology, and electrophysiology. The company was founded by Purnendu Chatterjee in 1998 and is headquartered in Kolkata, India. | Commercial Services |
Osiris Therapeutics, Inc.
Osiris Therapeutics, Inc. BiotechnologyHealth Technology Osiris Therapeutics, Inc. engages in the research, development, manufacture, and commercialization of regenerative medicine products. Its biosurgery business focuses on using unique tissue preservation technologies to develop viable human tissue products designed to improve wound closure and surgical outcomes for patients and physicians over standard of care alone. The company was founded by Peter A. Friedli and James S. Burns on December 23, 1992 and is headquartered in Columbia, MD. | Health Technology |